CD24 blockade promotes anti‐tumor immunity in oral squamous cell carcinoma

• Published in: Oral diseases Vol. 30; no. 2; pp. 163 - 171
• Main Authors: Zou, Ke‐Long, Lan, Zhou, Cui, Hao, Zhao, Yu‐Yue, Wang, Wei‐Ming, Yu, Guang‐Tao
• Format: Journal Article
• Language: English
• Published: Denmark Wiley Subscription Services, Inc 01.03.2024
• Subjects: Cancer; CD24; CD4 antigen; CD8 antigen; Cell number; Flow cytometry; Gene expression; Immunohistochemistry; immunotherapy; Lymphocytes T; Macrophages; Medical prognosis; oncology; Oral cancer; Oral carcinoma; Oral squamous cell carcinoma; Squamous cell carcinoma; Tumor microenvironment; Tumors; tumor‐associated macrophages; oral squamous cell carcinoma; CD24; oncology; immunotherapy; tumor-associated macrophages
• ISSN: 1354-523X; 1601-0825
• DOI: 10.1111/odi.14367

Objectives Our study elucidates the prognostic role of cluster of differentiation (CD) 24 expression in oral squamous cell carcinoma (OSCC) and determines whether targeting CD24 enhances the anti‐tumor immune response by inhibiting tumor‐associated macrophages (TAMs). Materials and Methods The expression of CD24 and CD68 was analyzed immunohistochemically via tissue microarrays constructed using 56 cohorts of patients with OSCC and 20 control specimens. Further, CD24 was inhibited in an allograft squamous cell carcinoma (SCC) related mouse model with CD24mAb to determine the tumor volume and weight. Changes in immune cells such as TAMs and T cells in the tumor microenvironment (TME) were analyzed by Flow cytometry. The expression of CD4, CD8, and Ki67 was analyzed via immunohistochemistry. The inhibition of CD24 was confirmed by Western blot and immunohistochemistry. Results CD24 was overexpressed in OSCC. High expression of CD24 indicated poor survival in patients with OSCC (p = 0.0334). CD24 expression was significantly correlated with CD68 (p = 0.0424). The inhibition of CD24 delayed tumor growth in vivo. A decrease in TAMs number and an increase in T cell number were confirmed, while the ability of tumor proliferation was impaired. Conclusion Targeting CD24 could enhance anti‐tumor immune response by inhibiting TAMs.